ANIP — ANI Pharmaceuticals Share News
0.000.00%
- $1.67bn
- $1.90bn
- $883.37m
U.S. STOCKS ON THE MOVE-Delta, Levi's, banks
Brief: Ani Pharmaceuticals Announces FDA Approval And Launch Of Isosorbide Mononitrate Tablet
U.S. STOCKS ON THE MOVE-Delta, GATX, Humana
ANI Pharmaceuticals jumps after launching generic heart drug
U.S. STOCKS ON THE MOVE-Talen Energy, Applied Optoelectronics, oil companies
U.S. STOCKS ON THE MOVE-Oil companies, Arlo Technologies, AES
U.S. STOCKS ON THE MOVE-Netflix, Dell, Autodesk
ANI Pharma rises after quarterly results beat estimates
ANI Pharma Q4 profit beats on rare disease, generics growth; reaffims forecast
Brief: ANI Pharmaceuticals Announces Board Transition
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR
U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT
ANI Pharma rises on Q3 results beat, FY revenue forecast raise
ANI Pharmaceuticals beats Q3 revenue estimates on Cortrophin demand
Brief: ANI Pharmaceuticals Q3 Adjusted EPS USD 2.04 Vs. IBES Estimate USD 1.75
U.S. RESEARCH ROUNDUP- Autozone, Pfizer, Valley National Bancorp
Does a common heart attack pill help everyone? Studies disagree
U.S. RESEARCH ROUNDUP -ANI Pharmaceuticals, Berkshire Hathaway, Chevron